SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (1732)2/19/2002 2:34:37 PM
From: Bob Rudd  Read Replies (1) of 10345
 
Jon: This is a tough one to figure. Pessimism is clearly extreme...which in this Enron driven environment is understandable. More understandable, frankly, than Elan's convoluted financials. Which is why I'm going to keep this a very small position. Several directors buying 220+k shares at current levels is a big positive [If it's real...not covered by some backwater non-recourse loan]. I suspect there are some exciting 'Real options' buried in the R&D. Ideal situation would be a merger and if the values are similar to what you've layed out, this would be accretive to earnings and science portfolio of nearly any pharma.
Thanks for clarifying the cash/stock net of debt thing and thanks again for the valuations.
bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext